Banks and private credit firms are competing to provide at least $5 billion of debt financing to help fund a potential buyout ...

The potential sale of its 88% stake in Bausch + Lomb could generate billions for creditors and shareholders of the indebted ...

Bullish option flow detected in Bausch Health (BHC) with 5,026 calls trading, 2x expected, and implied vol increasing over 2 ...

Evercore ISI upgraded shares of Bausch + Lomb (NYSE:BLCO – Free Report) from an in-line rating to an outperform rating in a ...

Bausch Health has recently changed its strategy for Bausch + Lomb, looking to sell the segment which has a market capitalization of nearly $8 billion. The potential sale of Bausch + Lomb is a break ...

Evercore ISI upgraded shares of Bausch Health Companies (TSE:BHC – Free Report) to a hold rating in a research note published ...

Thirty years ago, Bill T. Jones presented “Still/Here,” and the critic Arlene Croce responded with an explosive essay. Now ...

Fintel reports that on October 15, 2024, Evercore ISI Group upgraded their outlook for Bausch + Lomb (NYSE:BLCO) from In-Line ...

S&P Global's Joe Mantone puts the latest M&A data in perspective and how deal pros might react post-Election Day.

In a report released yesterday, Larry Biegelsen from Wells Fargo assigned a Buy rating on Bausch + Lomb Corporation (BLCO – Research ...

CHICAGO -- An investigational dual-action inhibitor for geographic atrophy (GA) significantly slowed disease progression and ...